Projektinformation

Beskrivning

VALproate as First line therapy in combination with RItuximab and CHOP in Diffuse large B-cell lymphoma – a phase I trial ongoing in Lund, Umeå and Uppsala. NCT01622439
StatusEj startat

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi